Palumbo Wealth Management LLC
Position in TSHA — Taysha Gene Therapies, Inc.
CIK 1846310
GREAT NECK, NY
Position in TSHA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$655,789
-$323,249 QoQ
Shares Held
146,709
-17.6% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Palumbo Wealth Management LLC holds $15,072,882 across 31 Biotechnology names. TSHA ranks #10 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
10,360 | $869,411 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
37,183 | $868,594 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
22,888 | $762,628 | |
| 4 | DSGN |
Design Therapeutics, Inc.
|
71,408 | $759,781 | |
| 5 | NVAX |
Novavax Inc
|
92,111 | $749,783 | |
| 6 | NKTR |
Nektar Therapeutics
|
10,173 | $731,947 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
37,966 | $717,557 | |
| 8 | IMNM |
Immunome Inc.
|
32,051 | $700,955 |
All Filings in TSHA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $655,789 | 146,709 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $979,038 | 178,007 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $514,544 | 157,353 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||